MENU
MLTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MoonLake Immunotherapeutics (MLTX) Ownership - Who owns MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more
Profile
Industry
N/A
Address
Dorfstrasse 29
Phone
+41 415108022
Employees
50
Web
https://www.moonlaketx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.54B
P/E Ratio
N/A
Total Cash
425.08M
Projected Growth
N/A
Total Debt
75.77M
Revenue
N/A
Risk (Beta)
0.91
Dividend Yield
N/A
Total Cash/Share
6.69
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MLTX
Capitalization
3.54B
P/E Ratio
N/A
Risk (Beta)
0.91
Dividend Yield
N/A
Total Cash
425M
Total Cash/Share
6.69
Total Debt
75.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
354M
P/B Ratio
10.01
Cash Flow
N/A
Earnings
-2.79
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
16.65
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-196.98M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.06
Shares Held By Institutions
3.51B
Shares Outstanding - Current
63.5M
Total Liabilities
102M
Total Volume MTD
N/A
Value
N/A
Gain YTD
2.955
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MLTX showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Dorfstrasse 29
Phone
+41 415108022
Employees
50
Web
https://www.moonlaketx.com